PI-103 can not only inhibit PI3K, but it also inhibits mTOR and DNA-dependent protein kinase, a feature that has been used in a variety of in vivo efficacy models, and can even have a certain effect on glioblastomas (31). Here, MTOR is linked to glioblastoma.